可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]Lietz K, Miller LW. Improved surviral of patients with end-stage heart failure listed for heart transplantation: analysis of organ procurement and transplantation network/U.S.United Network of Organ Sharing data, 1990 to 2005[J]. J Am Coll Cardiol, 2007, 50(13):1282-1290.
[2]赵晓静,彭卓,屈莉,等. 地高辛低血浓度与慢性心力衰竭的疗效[J]. 心脏杂志, 2009, 21(2):248-250,254.
[3]华宁,唐发宽,钮炜西,等. 坎地沙坦对老年充血性心力衰竭患者利钾尿肽、心房钠尿肽和内皮素水平的影响[J]. 心脏杂志, 2009, 21(6):828-831.
[4]郭宪清,张丽香,房立丽. 厄贝沙坦治疗慢性心力衰竭的疗效观察[J]. 心脏杂志, 2009, 21(2):264-266.
[5]胡刘华,单培仁,何奔. 钠尿肽抗心衰治疗的研究进展[J]. 心脏杂志, 2008, 20(5):644-648.
[6]刘勇. 临床心脏起搏与电生理学技术和方法的回顾与展望[J]. 生物医学工程学进展, 2009, 30(3):175-177.
[7]Jolicoeur EM, Granger CB, Fakunding JL, et al. Bringing cardiovascular cell-based therapy to clinical application: perspectives based on a National Heart, Lung, ang Blood Institute Cell Therapy Working Group meeting[J]. Am Heart J, 2007, 153(5):732-742.
[8]Allen R, Kass M, Glover C, et al. Cellular transplantation: future therapeutic options[J]. Curr Opin Cardiol, 2007, 22(2):104-110.
[9]Menasche P. Stem cell therapy for heart failure are arrhythmias a real safety concern?[J]. Circulation, 2009, 119(20):2735-2740.
[10]Seidman JG, Pyeritz RE, Seidman CE. Genetic factors in myocardial diseasep[M]//. Libby P, Bonow RO, Mann DL, et al. Braunwald’s Heart Disease. 8th ed. Philadelphia: Elsevier, 2008:111-123.
[11]Iakoubova OA, Sabstine MS, Rowland CM, et al. Polymorphism in K1F6 gene and benefit from statins after acute coronary syndromes[J]. J Am Coll Cardiol, 2008, 51(4):449-455.
[12]Liggett SB, Mialet-Perez J, Thaneemit-Chen S, et al. A polymorphism within an observed bl-adtenergic receptor mitif alters cardiac function and beta blocker response in human heart failure[J]. Proc Natl Acad Sci USA, 2006, 103(30):11288-11293.